Bloomberg -- Bayer AG would be able to finance a deal as big as the 17 billion-euro ($22.9 billion) takeover of Schering AG as it seeks to expand the drug unit, said Marijn Dekkers, who takes over as chief executive officer on Oct. 1.
Bloomberg -- Bayer AG would be able to finance a deal as big as the 17 billion-euro ($22.9 billion) takeover of Schering AG as it seeks to expand the drug unit, said Marijn Dekkers, who takes over as chief executive officer on Oct. 1.
